Asako Nagata

1.5k total citations · 1 hit paper
8 papers, 623 citations indexed

About

Asako Nagata is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Asako Nagata has authored 8 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Asako Nagata's work include Hormonal and reproductive studies (2 papers), Estrogen and related hormone effects (2 papers) and Prostate Cancer Treatment and Research (2 papers). Asako Nagata is often cited by papers focused on Hormonal and reproductive studies (2 papers), Estrogen and related hormone effects (2 papers) and Prostate Cancer Treatment and Research (2 papers). Asako Nagata collaborates with scholars based in United States, Italy and Poland. Asako Nagata's co-authors include Brion W. Murray, James Solowiej, Meirong Xu, Simon Bergqvist, Revati Wani, Ping Chen, Rose Ann Ferre, Xiu Yu, Nathan V. Lee and Todd VanArsdale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Nature Chemical Biology.

In The Last Decade

Asako Nagata

8 papers receiving 617 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance

2016 307 citations Ping Chen, Nathan V. Lee et al. Molecular Cancer Therapeutics profile →

Peers

Countries citing papers authored by Asako Nagata

Since Specialization

Citations

This map shows the geographic impact of Asako Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asako Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asako Nagata more than expected).

Fields of papers citing papers by Asako Nagata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asako Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asako Nagata. The network helps show where Asako Nagata may publish in the future.

Co-authorship network of co-authors of Asako Nagata

This figure shows the co-authorship network connecting the top 25 collaborators of Asako Nagata. A scholar is included among the top collaborators of Asako Nagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asako Nagata. Asako Nagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes 2024 ·Nature Chemical Biology ·(unknown), Zhonglin Liu, Marscha Hirschi, Oleg Brodsky, Eric F. Johnson, (unknown), Asako Nagata, Divya Bezwada, Matthew D. Petroski, Jaimeen D. Majmudar, Sherry Niessen, Todd VanArsdale, A. Gilbert, Matthew M. Hayward, Al Stewart, Andrew R. Nager, Bruno Melillo, Benjamin F. Cravatt	7
2	Critical Assessment of State‐of‐the‐Art Ligand‐Based Virtual Screening Methods 2022 ·Molecular Informatics ·Simone Sciabola, Rubben Torella, Asako Nagata, Markus Boehm	8
3	Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers 2018 ·PLoS ONE ·Luping Qiu, Kymberly K. Levine, K.S. Gajiwala, Ciarán N. Cronin, Asako Nagata, Eric F. Johnson, Michelle L. Kraus, John Tatlock, Robert S. Kania, Timothy L. Foley, Shaoxian Sun	16
4	Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance breakdown → 2016 ·Molecular Cancer Therapeutics ·Ping Chen, Nathan V. Lee, Wenyue Hu, Meirong Xu, Rose Ann Ferre, Hieu Lam, Simon Bergqvist, James Solowiej, Wade Diehl, You-Ai He, Xiu Yu, Asako Nagata, Todd VanArsdale, Brion W. Murray	307
5	Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacology 2014 ·Frontiers in Pharmacology ·Revati Wani, Asako Nagata, Brion W. Murray	57
6	Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance 2013 ·Proceedings of the National Academy of Sciences ·Phillip A. Schwartz, Petr Kuzmič, James Solowiej, Simon Bergqvist, Ben Bolaños, Chau Almaden, Asako Nagata, Kevin Ryan, Junli Feng, Deepak Dalvie, John C. Kath, Meirong Xu, Revati Wani, Brion W. Murray	197
7	Design of oxobenzimidazoles and oxindoles as novel androgen receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·Chuangxing Guo, Mason Pairish, Angelica Linton, Susan E. Kephart, Martha A. Ornelas, Asako Nagata, Benjamin J. Burke, Liming Dong, (unknown), Andrea Fanjul	20
8	Discovery of 3-aryloxy-lactam analogs as potent androgen receptor full antagonists for treating castration resistant prostate cancer 2011 ·Bioorganic & Medicinal Chemistry Letters ·Chuangxing Guo, Susan E. Kephart, Martha A. Ornelas, Javier González, Angelica Linton, Mason Pairish, Asako Nagata, S.E. Greasley, Jeff Elleraas, Natilie Hosea, (unknown), Andrea Fanjul	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact